<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00831948</url>
  </required_header>
  <id_info>
    <org_study_id>08-CIR-02- Dr ROUZIER</org_study_id>
    <nct_id>NCT00831948</nct_id>
  </id_info>
  <brief_title>Identification of Large-Scale Mutations of POLG Gene by QMPSF in Patients With Mitochondrial DNA Instability.</brief_title>
  <official_title>Identification of Large-Scale Mutations of POLG Gene by QMPSF in Patients With Mitochondrial DNA Instability.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mitochondrial diseases are a heterogeneous group caused by genetic defects in mitochondrial
      DNA or in nuclear genes. POLG is the most frequently involved gene in mtDNA instability
      diseases resulting in mtDNA multiple deletion and/or depletion. It encodes the DNA polymerase
      gamma (POLγ), the only known DNA polymerase found in mammalian mitochondria. Mutations in
      POLG could explain 45% of familial progressive external ophtalmoplegia associated with
      multiple mtDNA deletions. However, in more than 70%, the analysis of the genes involved in
      mtDNA instability remains unsuccessful.

      To date, these genes are screened by sequencing methods that are not able to detect
      large-scale rearrangements. In order to detect possible large-scale rearrangements, the
      investigators propose to develop a new assay based on QMPSF (Quantitative Multiplex PCR of
      Short fluorescent Fragments) able to detect exon deletions and duplications. the
      investigators propose to screen the POLG gene by QMPSF in at least twenty patients with
      either no mutation or only one mutation detected in POLG and no mutation in other genes such
      as TWINKLE and ANT1.

      This study would allow the investigators to know if large-scale rearrangements occur in the
      POLG gene and to estimate their frequency in patients with mtDNA instability. These data are
      important to know if the sequencing analysis of POLG should be completed by the screening for
      partial deletions and duplications to ensure an accurate molecular diagnosis of these
      syndromes. Moreover, this method could be extended to ANT1 and TWINKLE genes.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2008</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Improving the diagnosis of mitochondrial pathology</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Mitochondrial Diseases</condition>
  <condition>Diagnosis</condition>
  <condition>DNA Mutations</condition>
  <arm_group>
    <arm_group_label>Mitochondrial disease</arm_group_label>
    <description>Patients already diagnosed for mitochondrial pathology without mtDNA mutations yet detected by current diagnostic techniques</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>mitochondrial DNA mutations diagnosis</intervention_name>
    <description>Identification of large-scale mutations of POLG gene by QMPSF in patients with mitochondrial DNA instability.</description>
    <arm_group_label>Mitochondrial disease</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients already diagnosed for mitochondrial pathology without mtDNA mutations yet detected
        by current diagnostic techniques
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients already diagnosed for mitochondrial pathology without mtDNA mutations yet
             detected by current diagnostic techniques
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cécile ROUZIER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cécile ROUZIER, MD</last_name>
    <phone>00-33(0)4.92.03.64.59</phone>
    <email>rouzier.c@chu-nice.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Nice- Hôpital ARCHET 2 -Laboratoire de Génétique Médicale</name>
      <address>
        <city>Nice</city>
        <zip>06200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cécile ROUZIER, MD</last_name>
      <phone>00-33 (0)4.92.03.64.59</phone>
      <email>rouzier.c@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Cécile ROUZIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2009</study_first_submitted>
  <study_first_submitted_qc>January 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2009</study_first_posted>
  <last_update_submitted>January 28, 2009</last_update_submitted>
  <last_update_submitted_qc>January 28, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 29, 2009</last_update_posted>
  <responsible_party>
    <name_title>Centre Hospitalier Universitaire de Nice</name_title>
    <organization>Département de la Recherche Clinique et de l'Innovation</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitochondrial Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

